Novartis Institutes for Biomedical Research
Dr. Wolf Heusermann is affiliated to Novartis Institutes for Biomedical Research, Novartis Institutes for Biomedical Research. Dr. Wolf Heusermann is currently providing services as Professor. Dr. Wolf Heusermann has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Wolf Heusermann contributions have acclaimed recognition from honourable subject experts around the world. Dr. Wolf Heusermann is actively associated with different societies and academies. Dr. Wolf Heusermann academic career is decorated with several reputed awards and funding. Dr. Wolf Heusermann research interests include Novartis Institutes for Biomedical Research.
A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status.